We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$697M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-7.3%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$314M
AUM Growth
-$88.6M
(-22%)
Cap. Flow
-$54.8M
Cap. Flow
% of AUM
-17.46%
Top 10 Holdings %
Top 10 Hldgs %
50.02%
Holding
85
New
12
Increased
22
Reduced
16
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$13.3M |
| 2 |
Cigna
CI
|
+$11.1M |
| 3 |
Merck
MRK
|
+$9.51M |
| 4 |
Cardinal Health
CAH
|
+$5.84M |
| 5 |
RCOR
Renovacor, Inc.
RCOR
|
+$5.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$8.71M |
| 2 |
Amgen
AMGN
|
+$8.53M |
| 3 |
AFMD
Affimed
AFMD
|
+$6.07M |
| 4 |
Coherus Oncology
CHRS
|
+$5.72M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$5.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.44% |
| 2 | Consumer Staples | 2.92% |
| 3 | Industrials | 0.71% |
| 4 | Financials | 0.56% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
76
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-6,290
| Closed | -$2.14M |
|
77
ProQR Therapeutics
PRQR
$278M
| – | – |
-380,045
| Closed | -$2.56M |
|
78
Seer Inc
SEER
$121M
| – | – |
-23,775
| Closed | -$779K |
|
79
Travere Therapeutics
TVTX
$5.92B
| – | – |
-150,000
| Closed | -$2.19M |
|
|
NARI
80
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-46,332
| Closed | -$4.32M |
|
|
BCEL
81
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| – | – |
-113,455
| Closed | -$967K |
|
|
SYNH
82
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – |
-62,598
| Closed | -$5.6M |
|
|
HRC
83
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| – | – |
-76,647
| Closed | -$8.71M |
|
|
CHAQ.U
84
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
| – | – |
-400,000
| Closed | -$4.37M |
|
|
AHACU
85
DELISTED
Alpha Healthcare Acquisition Corp Unit
AHACU
| – | – |
-100,000
| Closed | -$1.14M |
|
Similar funds
GUB
KLI
JA
WIC
AAM
TCM
CA
SAM
Sio Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Sio Capital Management held 85 positions worth $314M, down 22% from $402M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Sio Capital Management withdrew a net $54.8M in Q3 2021, closing 24 positions and reducing 16 holdings. Its most notable exit was HILL-ROM HOLDINGS, INC., an estimated $8.71M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 79% a quarter earlier, followed by Consumer Staples and Industrials.
Against the trend, Sio Capital Management opened a new position in Lakefront Biotherapeutics American Depositary Shares worth $11.8M.
- Sio Capital Management's largest Q3 2021 buy was Lakefront Biotherapeutics American Depositary Shares: 224,719 shares worth $11.8M.
- Sio Capital Management added most to Cigna in Q3 2021, an estimated $11.1M increase.
- Sio Capital Management's biggest Q3 2021 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $3.96M.
- Sio Capital Management fully exited HILL-ROM HOLDINGS, INC. in Q3 2021, selling an estimated $8.71M.
- Sio Capital Management's ten largest holdings make up 50% of its $314M portfolio in Q3 2021.
- Sio Capital Management opened 12 new positions and closed 24 in Q3 2021.
- Sio Capital Management's portfolio value fell 22% quarter-over-quarter to $314M.
Based on Sio Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.